インスリン分泌:SIRT4が介入する
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis Pasteur, 67404 Illkirch Cedex, France.
Cell
|September 9, 2006
まとめ
サートゥインは代謝を調節する. この研究では,SIRT4が臓のβ細胞でADP-リボシライゼーションを使用してグルタミン酸脱水素酶を阻害し,アミノ酸によって刺激されるインスリン分泌を減少させることを示しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- メタボリック・レギュレーション
背景:
- サートゥイン (サイレント情報レギュレータ2) は,エウカリオットに保存されているタンパク質のクラスです.
- 当初は,転写調節に関与するヒストン脱エチラゼと特定された.
- 代謝調節における新興の役割は,より広範な生物学的意義を強調しています.
研究 の 目的:
- 哺乳類のシルトゥインホモログであるSIRT4が代謝調節における役割を調査する.
- SIRT4が臓のβ細胞機能に影響を与えるメカニズムを解明する.
- アミノ酸への反応としてインスリン分泌の調節を理解する.
主な方法:
- 臓のβ細胞におけるSIRT4のミトコンドリアの局所化.
- SIRT4の酵素活性,特にADP-リボシライゼーションの分析.
- Glutamate dehydrogenaseの活性に対するSIRT4の影響を評価する.
- ベータ細胞からのインスリン分泌を様々な条件下で測定する.
主要な成果:
- SIRT4は,臓β細胞のミトコンドリアに局所する.
- SIRT4はADP-リボシライゼーション経由でグルタミン酸脱水素酶の活性を直接抑制する.
- この抑制は,アミノ酸刺激への反応として,インスリン分泌の抑制につながる.
結論:
- SIRT4はミトコンドリアのシルトゥインで,臓のβ細胞機能を調節する上で重要な役割を果たします.
- グルタミン酸脱水素酵素のADP-リボシレーションにより,SIRT4はアミノ酸誘発インスリン分泌を調節する.
- これらの発見は,サーチューイン,ミトコンドリア代謝,内分泌機能を結びつける新しいメカニズムを明らかにしています.
さらに関連する動画
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
18.9K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.1K
関連する概念動画
01:40Hormonal Regulation
37.6K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
37.6K
01:58Cell Specific Gene Expression
13.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
01:16Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
01:28Insulin: The Receptor and Signaling Pathways
6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K